NCT01094093 Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 139 in Healthy Subjects and Subjects With Moderate to Severe Psoriasis Status COMPLETED Phase PHASE1
NCT01090427 A Study of the Safety and Efficacy of Ustekinumab in Adolescent Patients With Psoriasis (CADMUS) Status COMPLETED Phase PHASE3
NCT01088165 The Influence of Adalimumab on Cardiovascular and Metabolic Risk in Psoriasis Status UNKNOWN Phase PHASE4
NCT01081730 Ustekinumab Safety and Surveillance Program Using the Ingenix NHI Database Status COMPLETED Phase N/A
NCT01079988 Study of Therapeutic Options for Subjects Discontinuing Efalizumab and Experiencing Disease Recurrence Status COMPLETED Phase PHASE4
NCT01077882 Analysis of the Quality of Life, the Clinical Effectiveness and Cost-effectiveness of a Novel Educational Programme in Patients With Psoriasis and Atopic Dermatitis Status COMPLETED Phase PHASE4
NCT01077128 Greek Study of the Quality of Life in Patients With Psoriasis Treated With Adalimumab Status COMPLETED Phase N/A
NCT01059773 A Safety and Efficacy Study of Ustekinumab in Patients With Plaque Psoriasis Who Have Had an Inadequate Response to Methotrexate Status COMPLETED Phase PHASE4
NCT01045577 A Double-blind, Placebo-controlled, Randomized, Parallel-group Study to Evaluate the Activity of Oral AB1010 in Adults Patients With Moderate to Severe Chronic Plaque Psoriasis Status COMPLETED Phase PHASE2
NCT01045395 Efficacy of Two Algae Formulations on Lipid Metabolism, Inflammation and Oxidative Stress Status in Individuals With Psoriasis Status COMPLETED Phase PHASE1
NCT01043393 Desoximetasone Spray 0.25%, Hypothalamic Pituitary Adrenal (HPA) Axis Study Status COMPLETED Phase PHASE2
NCT01039142 Dose Ranging Study to Assess the Efficacy and Safety of Acitretin in Severe Plaque Type Psoriasis Status COMPLETED Phase PHASE4
NCT01029405 Safety and Efficacy Study of a Novel Ointment to Treat Plaque Type Psoriasis Status COMPLETED Phase PHASE2
NCT01019200 Serum Lipid Levels and Other Biomarkers of Cardiovascular Disease in Patients With Psoriasis Status COMPLETED Phase N/A